Please login to the form below
MSD
This page shows the latest MSD news and features for those working in and with pharma, biotech and healthcare.
MSD’s Keytruda to be made available in England for advanced cervical cancer patients
MSD’s – known as Merck &Co in the US and Canada – Keytruda (pembrolizumab) in combination with chemotherapy will be made immediately available to hundreds of advanced cervical cancer patients through ... Advanced cervical cancer is an aggressive
Latest news
-
AstraZeneca’s mild combination asthma reliever approved in UK
The authorisation comes just days after AZ and MSD’s – known as Merck &Co in the US and Canada – Lynparza (olaparib) was approved by the MHRA as part of a combination
-
Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
Merck – known as MSD outside the US and Canada – has reported positive results from a phase 3 study of its anti-PD-1 therapy Keytruda (pembrolizumab) in combination with chemotherapy for
-
AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
AstraZeneca and MSD's – known as Merck &Co in the US and Canada – Lynparza (olaparib) has been approved in the UK as part of a combination therapy for certain prostate cancer ... David Long, head of oncology at MSD UK, added: “This approval from
-
Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate
Merck &Co – known as MSD outside the US and Canada – has signed a worldwide licensing deal worth up to $922.5m with Opko Health’s ModeX Therapeutics unit for its experimental
-
FDA approves intramuscular administration of Merck’s MMRV vaccines
The US Food and Drug Administration (FDA) has approved the intramuscular administration of Merck’s – known as MSD outside the US and Canada – measles, mumps, rubella and varicella (MMRV) family of
More from news
Approximately 91 fully matching, plus 431 partially matching documents found.
Latest Intelligence
-
Envisioning a healthier every day, for every woman
By Sandy Lindsey. It’s little over a year since the bell first rang on the New York Stock Exchange announcing the arrival of Organon &Co, a spin-off from MSD
-
Customers, content and change
We are living in a world of distraction and the battle is one for ‘mindshare’,” said Florent Bühler, MSD’s omnichannel and customer experience lead – EUCAN Oncology.
-
Diversity in Pharma: The Impact of COVID-19 on DE&I
Meet the panel:. Andrés López Castaño, Vaccine Therapeutic Area Lead, Global LGBTQI+ ERG Lead, MSD Switzerland. ... He currently leads D&I for the Europe LGBT+ Employee Resource Network, the Zurich office as well as the Global Data Management
-
Alzheimer’s disease: the search for a cure
The companies, Abbvie, Astex Pharmaceuticals, Eisai, Johnson &Johnson, Lilly, MSD and Takeda, Evotec and Charles River, participate in research projects alongside academic scientists.
-
NICE – but not enough
A great example is Steglatro, MSD’s treatment for type 2 diabetes. ... Armed with positive NICE guidance, MSD did a great job of getting Steglatro on formulary.
More from intelligence
Approximately 4 fully matching, plus 38 partially matching documents found.
Latest appointments
-
90TEN Medical appoints Niamh Mangan as its new managing director
Middleton moved to 90TEN from MSD and has over 13 years of both in-house and agency experience in healthcare communications, public relations and policy.
-
ENGINE MHP+Mischief bolsters healthcare comms expertise with new senior hires
She has also worked in roles at MSD, M&C Saatchi, the House of Commons and NCT.
-
GCI Health’s UK team announces three senior promotions
Before joining GCI Health, Yianni (pictured left) worked at pharmaceutical company MSD as a strategic project manager.
-
Merck & Co appoints Frank Clyburn as president, human health
Merck &Co – known as MSD outside the US and Canada – has appointed Frank Clyburn (pictured above) as president, human health.
-
Dan Russell joins Seven Stones as managing director
Pharmaceuticals, MSD and more.
More from appointments
Approximately 5 fully matching, plus 52 partially matching documents found.
Latest from PMHub
-
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
Many pharma companies, such as MSD, J&J and GSK, have already invested heavily in data and are driving effective omnichannel experiences to audiences using insights.
-
Lucid Group Bolster its Senior Leadership Team
The majority of Jo’s 15 years within pharma were spent at Sanofi Pasteur MSD where she held a number of senior marketing roles before moving agency-side to STEM, holding
-
Mednet Group
Johnson and Johnson. University of Leeds. Lundbeck Mind. MSD. Novo. Nordisk.
-
Onyx Health Expands with New Management Appointment
business such as Boots, the ProPharma Group and MSD.
-
HOW INNOVATION IS RESHAPING THE NORTH EAST LIFE SCIENCES LANDSCAPE
We have an enviable cluster of world class pharmaceutical manufacturers on our doorstep including Glaxo Smith Kline, MSD and Piramal Healthcare.
More from PMHub
Approximately 0 fully matching, plus 15 partially matching documents found.
Subscribe to our email news alerts
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- MSD’s Keytruda to be made available in England for advanced cervical cancer patients
- Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
- Improving cardiovascular disease care and awareness
- PMGroup announces launch of new recruitment platform PharmaRole
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- The state of pharma customer experience
- MHRA to introduce new UK clinical trials framework
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
